BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
TGFB1
,
T cell differentiation
,
Breast Cancer
,
Retina
,
Biofuel
,
Prozac
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Lysosome membrane protein II
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Medulla oblongata
Thymus gland
Corpus callosum
Nodose nucleus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Muscle cachexia
Sepsis due to Serratia
Huntington's disease
Pneumocystosis
Disorder of uterus
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Anti-Mullerian Hormone
Tuberculin
Timolol
dimethisoquin
Trimethoprim
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
TSR2
CCDC6
PFAS
FASN
GFI1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Embryonic stem cells differentiated in presence or absence of LIF
OMIM - Epilepsy disorders
Colonocytes undergoing oncogenesis treated with a fish oil/pectin or corn oil/cellulose diet
Spermatids and prepachytene and pachytene spermatocytes
Chemical modifications reduce silencing of partially-complementary transcripts by siRNAs
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Lysosome membrane protein II
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease
Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Recei…
Phase II Study of Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma
Gene Therapy for Male Patients With Danon Disease (DD) Using RP-A501; AAV9.LAMP2B
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ